Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1735822 | 1.00 | SLC6A2 (0.32) | SLC6A2SLC6A3 | |
| SCHEMBL9251530 | 0.72 | LMNA (0.31) | — | |
| SCHEMBL11383230 | 0.70 | LMNA (0.36) | — | |
| SCHEMBL10371759 | 0.68 | CES2 (0.33) | — | |
| SCHEMBL11104413 | 0.67 | HPGD (0.33) | SLC6A2SLC6A3 | |
| SCHEMBL16446965 | 0.67 | HPGD (0.33) | SLC6A2SLC6A3 | |
| SCHEMBL1799677 | 0.67 | HPGD (0.33) | SLC6A2SLC6A3 | |
| SCHEMBL8718896 | 0.67 | HPGD (0.34) | — | |
| SCHEMBL6142770 | 0.67 | HPGD (0.33) | SLC6A2SLC6A3 | |
| SCHEMBL9614440 | 0.67 | HPGD (0.33) | SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4138850-A1 | ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E | Janssen Pharmaceuticals, Inc. (US) | 2023-03-01 | — | — | EP | disclosed |
| WO-2021209425-A9 | ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E | Janssen Pharmaceuticals, Inc. (US) | 2022-12-22 | — | — | WO | disclosed |